Fellowship · Louisville, KY
Sponsored by University of Louisville School of Medicine
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
Lancet (London, England) · 2021 · 476 citations · Dawn Caster
Safety and Efficacy of Long-Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical Trial.
Arthritis & rheumatology (Hoboken, N.J.) · 2024 · 95 citations · Dawn Caster
The Treatment of Primary IgA Nephropathy: Change, Change, Change.
American journal of kidney diseases : the official journal of the National Kidney Foundation · 2024 · 43 citations · Dawn Caster
Glucarpidase for treatment of high-dose methotrexate toxicity.
Blood · 2025 · 25 citations · Ashwini Pujari
KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases.
American journal of kidney diseases : the official journal of the National Kidney Foundation · 2023 · 52 citations · Dawn Caster
A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients.
JCI insight · 2021 · 107 citations · Kenneth Mcleish
Update on the Efficacy and Safety Profile of Voclosporin: An Integrated Analysis of Clinical Trials in Lupus Nephritis.
Arthritis care & research · 2023 · 38 citations · Dawn Caster
The role of stents in hemodialysis vascular access.
The journal of vascular access · 2023 · 16 citations · Amy Dwyer